Moderna announced that it is seeking an emergency use authorization from the FDA for an additional booster dose of its COVID-19 vaccine for all adults.
The company applied for the EUA for anyone aged 18 years or older who has already received a booster dose of any authorized COVID-19 vaccine.
The submission was based partly on data from Israel and the United States following the emergence of the omicron variant that demonstrated the benefits of an additional dose of the vaccine, according to a press release.
The company did not specify what the data showed, but a recently published study in The